Summary
Updated Aug 31, 2026
Niro Ph.D Ramachandran is Chief Business Officer of Akoya Biosciences, Inc. (AKYA). 2 SEC Form 4 filings on record going back to 2024, most recently on 8 July 2025.
Recent Transactions
5Every recent SEC Form 4 transaction Niro Ph.D Ramachandran has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Niro Ph.D Ramachandran's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Jeffrey M. Leiden - $60.94M of VRTX open-market activity in the last 12 months
- Vivek Ramaswamy - $60.40M of ROIV open-market activity in the last 12 months
- David Cordani - $60.11M of CI open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $60.00M of KOD open-market activity in the last 12 months
- Deep Track Biotechnology Master Fund, Ltd. - $60.00M of LBRX open-market activity in the last 12 months
- AI DMI LLC - $59.87M of IRON open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Niro Ph.D Ramachandran?
Niro Ph.D Ramachandran is a corporate insider, tracked as Chief Business Officer of Akoya Biosciences, Inc. (AKYA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Niro Ph.D Ramachandran last file a Form 4?
The most recent primary Form 4 on record is dated 8 July 2025, one of 2 filings going back to 2024.
Where can I see all of Niro Ph.D Ramachandran's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Niro Ph.D Ramachandran and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
